EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Microbiota composition and intestinal barrier function modulated by tamsulosin and Lactococcus lactis in a cirrhosis rat model

Silvia Valeria Padilla-García, Abraham Loera-Muro, Martín Humberto Muñoz-Ortega, David Alejandro Hernández-Marín, Javier Ventura-Juárez, Sandra Luz Martínez-Hernández

Frontiers in Cellular and Infection Microbiology · 2025

DOI: 10.3389/fcimb.2025.1624065 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2025. Verfasst von Silvia Valeria Padilla-García und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Morphology, Center for Basic Sciences, Autonomous University of Aguascalientes, Aguascalientes, Ags, Mexico. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Tamsulosin, Lactococcus lactis, Intestinal Mucosa. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The pathological progression of cirrhosis disrupts the gut-liver axis. Lactococcus lactis ( L. lactis ) exhibits immunomodulatory properties and an ability to enhance intestinal barrier function. It has been demonstrated that tamsulosin has antifibrotic and anti-inflammatory effects in hepatic injury models. This study evaluated the effect of a tamsulosin and L. lactis co-treatment on the recovery of microbiota and intestinal barrier integrity in a Wistar rat liver cirrhosis model. Material and methods Male Wistar rats were administered CCl 4 intraperitoneally for 4 weeks. Subsequently, rats received tamsulosin, L. lactis , or both, orally for 2 weeks. The intestinal microbiota was assessed using 16S rRNA gene sequencing. Intestinal barrier integrity was evaluated using qPCR and Western blot for proteins ZO-1, occludin, and claudin-2. Bacterial translocation was evaluated by endotoxin concentration, bacterial DNA, and microbial culture of extraintestinal tissues. Finally, hepatic, intestinal histology, and liver function markers were analyzed.

Results

L. lactis and its combination with tamsulosin (T/ L. lactis ) increased microbial diversity and promoted a balanced gut microbiota characterized by a Firmicutes predominance followed by Proteobacteria and reduced Clostridia and Gammaproteobacteria levels. L. lactis group upregulated ZO-1 and occludin expression, while no significant changes were observed with tamsulosin or T/ L. actis groups, nonetheless, intestinal morphology resembled that of healthy controls. Bacterial translocation analysis revealed no endotoxins, bacterial DNA, or bacteria in extraintestinal tissues. Both treatments also improved hepatic and intestinal histology, with partial liver function recovery. Conclusión Findings such as reduced bacterial translocation, lower systemic endotoxin levels, improved intestinal morphology, and modulation of gut microbiota composition suggest that both agents ( L. lactis and tamsulosin), particularly in combination, exert positive effects on the intestinal barrier in cirrhosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeTamsulosinLactococcus lactisIntestinal MucosaLiver CirrhosisProbioticsAnimalsRats, WistarMaleRatsDisease Models, AnimalBacterial TranslocationRNA, Ribosomal, 16SLiverOccludinZonula Occludens-1 ProteinBacteriaIntestinal Barrier Function

Stichwörter der Autor:innen

L. lactisbacterial translocationcirrhosisintestinal permeabilitymicrobiotatamsulosin

Substanzen

TamsulosinRNA, Ribosomal, 16SOccludinZonula Occludens-1 Protein

Autor:innen und Institutionen

  • Department of Morphology, Center for Basic Sciences, Autonomous University of Aguascalientes, Aguascalientes, Ags, Mexico.
  • Secihti-Center for Biological Research of the Northwest, SC, La Paz, Mexico.
  • Department of Chemistry, Center for Basic Sciences, Autonomous University of Aguascalientes, Aguascalientes, Ags, Mexico.
  • Department of Microbiology, Center for Basic Sciences, Autonomous University of Aguascalientes, Aguascalientes, Ags, Mexico.

Zitieren

APA

Padilla-García, S. V., Loera-Muro, A., Muñoz-Ortega, M. H., Hernández-Marín, D. A., Ventura-Juárez, J., & Martínez-Hernández, S. L. (2025). Microbiota composition and intestinal barrier function modulated by tamsulosin and Lactococcus lactis in a cirrhosis rat model. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2025.1624065

Vancouver

Padilla-García SV, Loera-Muro A, Muñoz-Ortega MH, Hernández-Marín DA, Ventura-Juárez J, Martínez-Hernández SL. Microbiota composition and intestinal barrier function modulated by tamsulosin and Lactococcus lactis in a cirrhosis rat model. Frontiers in Cellular and Infection Microbiology. 2025. doi:10.3389/fcimb.2025.1624065

BibTeX
@article{PadillaGarca2025,
  author = {Padilla-García, Silvia Valeria and Loera-Muro, Abraham and Muñoz-Ortega, Martín Humberto and Hernández-Marín, David Alejandro and Ventura-Juárez, Javier and Martínez-Hernández, Sandra Luz},
  title = {Microbiota composition and intestinal barrier function modulated by tamsulosin and Lactococcus lactis in a cirrhosis rat model},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2025},
  doi = {10.3389/fcimb.2025.1624065}
}
Kostenlos starten →